Literature DB >> 10575208

Exon structure and promoter identification of STIM1 (alias GOK), a human gene causing growth arrest of the human tumor cell lines G401 and RD.

S Sabbioni1, A Veronese, M Trubia, R Taramelli, G Barbanti-Brodano, C M Croce, M Negrini.   

Abstract

The stromal interaction molecular 1 gene (STIM1) encodes a type I trans-membrane protein of unknown function, which induces growth arrest and degeneration of the human tumor cell lines G401 and RD but not HBL100 and CaLu-6, suggesting a role in the pathogenesis of rhabdomyosarcomas and rhabdoid tumors. Here, we describe the STIM1 genomic organization including the identification of the promoter region. The gene consists of 12 exons that span a region larger than 250 kb between the genes RRM1 and NUP98. Nucleotide sequences of all exon-intron boundaries were determined and oligonucleotide primers for the amplification of individual exons were designed. The promoter region was identified within a 1.8-kb SacI fragment at the 5' end of the gene. In vitro CpG methylation of the promoter region indicated that transcription can be downregulated by this mechanism. The genetic tools developed in the present work will help to determine whether pathogenetic mechanisms that associate STIM1 with tumorigenesis involve mutations in coding sequences and/or promoter, and whether methylation could determine STIM1 transcriptional down-regulation in tumor samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575208     DOI: 10.1159/000015341

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  22 in total

1.  Stromal interaction molecule 1 (STIM1) silencing inhibits tumor growth and promotes cell cycle arrest and apoptosis in hypopharyngeal carcinoma.

Authors:  Yuanhao Sun; Xiaobo Cui; Jun Wang; Shuai Wu; Yunfei Bai; Yaping Wang; Boqian Wang; Jugao Fang
Journal:  Med Oncol       Date:  2015-04-02       Impact factor: 3.064

Review 2.  TRPC channels as STIM1-regulated store-operated channels.

Authors:  Paul F Worley; Weizhong Zeng; Guo N Huang; Joseph P Yuan; Joo Young Kim; Min Goo Lee; Shmuel Muallem
Journal:  Cell Calcium       Date:  2007-05-22       Impact factor: 6.817

Review 3.  Molecular pharmacology of store-operated CRAC channels.

Authors:  Amit Jairaman; Murali Prakriya
Journal:  Channels (Austin)       Date:  2013-08-26       Impact factor: 2.581

Review 4.  Store-operated CRAC channel inhibitors: opportunities and challenges.

Authors:  Chengsen Tian; Lupei Du; Yubin Zhou; Minyong Li
Journal:  Future Med Chem       Date:  2016-05-05       Impact factor: 3.808

5.  Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins.

Authors:  R T Williams; S S Manji; N J Parker; M S Hancock; L Van Stekelenburg; J P Eid; P V Senior; J S Kazenwadel; T Shandala; R Saint; P J Smith; M A Dziadek
Journal:  Biochem J       Date:  2001-08-01       Impact factor: 3.857

Review 6.  STIM1/Orai1-mediated SOCE: current perspectives and potential roles in cardiac function and pathology.

Authors:  Helen E Collins; Xiaoyuan Zhu-Mauldin; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-21       Impact factor: 4.733

7.  Molecular and functional characterization of non voltage-operated Ca entry in gastrointestinal neuroendocrine tumor cells.

Authors:  Sasi Arunachalam; Tetyana Zhelay; David R Giovannucci
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-05-19

8.  Wilms tumor suppressor 1 (WT1) and early growth response 1 (EGR1) are regulators of STIM1 expression.

Authors:  Michael F Ritchie; Chanyu Yue; Yandong Zhou; Peter J Houghton; Jonathan Soboloff
Journal:  J Biol Chem       Date:  2010-02-01       Impact factor: 5.157

Review 9.  STIMulating store-operated Ca(2+) entry.

Authors:  Michael D Cahalan
Journal:  Nat Cell Biol       Date:  2009-06       Impact factor: 28.824

Review 10.  Emerging roles of store-operated Ca²⁺ entry through STIM and ORAI proteins in immunity, hemostasis and cancer.

Authors:  Wolfgang Bergmeier; Carl Weidinger; Isabelle Zee; Stefan Feske
Journal:  Channels (Austin)       Date:  2013-03-19       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.